Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organogenesis Holdings (ORGO) Assets Average: 2017-2024

Historic Assets Average for Organogenesis Holdings (ORGO) over the last 8 years, with Dec 2024 value amounting to $479.0 million.

  • Organogenesis Holdings' Assets Average rose 9.16% to $485.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $485.5 million, marking a year-over-year increase of 9.16%. This contributed to the annual value of $479.0 million for FY2024, which is 5.34% up from last year.
  • As of FY2024, Organogenesis Holdings' Assets Average stood at $479.0 million, which was up 5.34% from $454.7 million recorded in FY2023.
  • Organogenesis Holdings' 5-year Assets Average high stood at $479.0 million for FY2024, and its period low was $255.5 million during FY2020.
  • In the last 3 years, Organogenesis Holdings' Assets Average had a median value of $454.7 million in 2023 and averaged $460.0 million.
  • Data for Organogenesis Holdings' Assets Average shows a peak YoY skyrocketed of 43.56% (in 2021) over the last 5 years.
  • Over the past 5 years, Organogenesis Holdings' Assets Average (Yearly) stood at $255.5 million in 2020, then soared by 43.56% to $366.7 million in 2021, then climbed by 21.70% to $446.3 million in 2022, then increased by 1.88% to $454.7 million in 2023, then grew by 5.34% to $479.0 million in 2024.